Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endothelial Cells | 16 | 2020 | 56 | 1.480 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 12 | 2017 | 42 | 1.100 |
Why?
|
| Capillary Permeability | 11 | 2013 | 27 | 1.080 |
Why?
|
| Lung | 16 | 2017 | 165 | 0.960 |
Why?
|
| Endothelium, Vascular | 8 | 2015 | 33 | 0.910 |
Why?
|
| RNA, Long Noncoding | 2 | 2022 | 21 | 0.890 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2023 | 31 | 0.830 |
Why?
|
| Pulmonary Artery | 4 | 2022 | 30 | 0.630 |
Why?
|
| Intercellular Junctions | 2 | 2008 | 7 | 0.550 |
Why?
|
| Mice | 21 | 2021 | 1390 | 0.540 |
Why?
|
| Cell Membrane | 4 | 2013 | 82 | 0.540 |
Why?
|
| Animals | 27 | 2021 | 3504 | 0.540 |
Why?
|
| Platelet Membrane Glycoproteins | 2 | 2013 | 6 | 0.500 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2013 | 26 | 0.500 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2013 | 10 | 0.480 |
Why?
|
| Hypertension, Pulmonary | 4 | 2020 | 14 | 0.440 |
Why?
|
| Enzyme Activation | 2 | 2013 | 105 | 0.430 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2016 | 13 | 0.430 |
Why?
|
| Ceramides | 1 | 2013 | 13 | 0.420 |
Why?
|
| Platelet Activating Factor | 2 | 2013 | 8 | 0.410 |
Why?
|
| Sex Characteristics | 3 | 2022 | 115 | 0.380 |
Why?
|
| Endocytosis | 6 | 2015 | 16 | 0.350 |
Why?
|
| Caveolae | 7 | 2015 | 14 | 0.350 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2008 | 7 | 0.300 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2008 | 5 | 0.300 |
Why?
|
| Neuropeptides | 1 | 2008 | 27 | 0.300 |
Why?
|
| Albumins | 2 | 2005 | 17 | 0.260 |
Why?
|
| Nitric Oxide | 2 | 2005 | 78 | 0.250 |
Why?
|
| Neutrophils | 4 | 2009 | 89 | 0.240 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 45 | 0.240 |
Why?
|
| Humans | 22 | 2023 | 25900 | 0.230 |
Why?
|
| RNA, Small Interfering | 5 | 2017 | 82 | 0.230 |
Why?
|
| Mice, Knockout | 8 | 2021 | 304 | 0.220 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2023 | 6 | 0.210 |
Why?
|
| Cell Proliferation | 4 | 2020 | 177 | 0.200 |
Why?
|
| Neutrophil Infiltration | 3 | 2009 | 9 | 0.200 |
Why?
|
| Cells, Cultured | 7 | 2020 | 506 | 0.200 |
Why?
|
| Sex Chromosomes | 1 | 2022 | 4 | 0.190 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 589 | 0.180 |
Why?
|
| Sepsis | 3 | 2009 | 111 | 0.180 |
Why?
|
| Phosphorylation | 2 | 2013 | 133 | 0.180 |
Why?
|
| Microscopy, Electron | 5 | 2013 | 58 | 0.170 |
Why?
|
| Actins | 2 | 2009 | 34 | 0.150 |
Why?
|
| Lung Diseases | 2 | 2017 | 43 | 0.150 |
Why?
|
| Microscopy, Fluorescence | 4 | 2013 | 77 | 0.150 |
Why?
|
| Caveolin 1 | 3 | 2007 | 5 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2015 | 16 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2015 | 22 | 0.140 |
Why?
|
| MAP Kinase Signaling System | 2 | 2019 | 37 | 0.140 |
Why?
|
| ets-Domain Protein Elk-1 | 2 | 2017 | 4 | 0.140 |
Why?
|
| Pyridones | 1 | 2017 | 10 | 0.140 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2017 | 35 | 0.140 |
Why?
|
| Vascular Remodeling | 1 | 2017 | 4 | 0.130 |
Why?
|
| SOS1 Protein | 1 | 2016 | 4 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2016 | 7 | 0.130 |
Why?
|
| Bone and Bones | 1 | 2017 | 116 | 0.130 |
Why?
|
| Escherichia coli Infections | 3 | 2005 | 25 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 65 | 0.130 |
Why?
|
| Basal Ganglia | 1 | 2015 | 14 | 0.120 |
Why?
|
| Blood-Brain Barrier | 1 | 2015 | 24 | 0.120 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2015 | 2 | 0.120 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2015 | 3 | 0.120 |
Why?
|
| Smad2 Protein | 1 | 2015 | 2 | 0.120 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2015 | 5 | 0.120 |
Why?
|
| Down-Regulation | 2 | 2015 | 104 | 0.120 |
Why?
|
| Lung Neoplasms | 2 | 2017 | 540 | 0.120 |
Why?
|
| Signal Transduction | 4 | 2015 | 431 | 0.120 |
Why?
|
| beta Catenin | 1 | 2015 | 63 | 0.120 |
Why?
|
| Knee Injuries | 1 | 2017 | 202 | 0.110 |
Why?
|
| Cerebral Hemorrhage | 1 | 2015 | 98 | 0.110 |
Why?
|
| Apoptosis | 3 | 2015 | 204 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 4 | 2015 | 42 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 3 | 2017 | 443 | 0.110 |
Why?
|
| Lipopolysaccharides | 3 | 2011 | 102 | 0.110 |
Why?
|
| Smoking | 1 | 2015 | 173 | 0.110 |
Why?
|
| Female | 5 | 2022 | 14543 | 0.110 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 25 | 0.110 |
Why?
|
| Immunoblotting | 1 | 2013 | 52 | 0.110 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2013 | 10 | 0.110 |
Why?
|
| Liposomes | 1 | 2013 | 13 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2013 | 248 | 0.100 |
Why?
|
| Cartilage, Articular | 1 | 2017 | 418 | 0.100 |
Why?
|
| Indoles | 2 | 2019 | 31 | 0.100 |
Why?
|
| Osteoarthritis, Knee | 1 | 2017 | 373 | 0.100 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 355 | 0.100 |
Why?
|
| Membrane Proteins | 3 | 2008 | 161 | 0.100 |
Why?
|
| Dynamin II | 1 | 2011 | 2 | 0.090 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2009 | 8 | 0.090 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2009 | 7 | 0.090 |
Why?
|
| Male | 9 | 2021 | 14176 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2011 | 68 | 0.080 |
Why?
|
| Lim Kinases | 1 | 2009 | 1 | 0.080 |
Why?
|
| Endothelium | 1 | 2009 | 12 | 0.080 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2009 | 5 | 0.080 |
Why?
|
| Acute Lung Injury | 1 | 2009 | 18 | 0.080 |
Why?
|
| T-Lymphoma Invasion and Metastasis-inducing Protein 1 | 1 | 2008 | 2 | 0.080 |
Why?
|
| Myosin Light Chains | 1 | 2008 | 3 | 0.080 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2008 | 13 | 0.080 |
Why?
|
| NG-Nitroarginine Methyl Ester | 2 | 2005 | 7 | 0.080 |
Why?
|
| Blood Vessels | 2 | 2005 | 12 | 0.080 |
Why?
|
| Protein Transport | 1 | 2008 | 32 | 0.080 |
Why?
|
| Phosphoproteins | 1 | 2008 | 26 | 0.080 |
Why?
|
| Cadherins | 1 | 2008 | 34 | 0.080 |
Why?
|
| Antigens, CD | 1 | 2008 | 50 | 0.070 |
Why?
|
| Qb-SNARE Proteins | 2 | 2005 | 5 | 0.070 |
Why?
|
| Qc-SNARE Proteins | 2 | 2005 | 5 | 0.070 |
Why?
|
| Cell Membrane Permeability | 1 | 2007 | 47 | 0.070 |
Why?
|
| Exocytosis | 1 | 2007 | 4 | 0.070 |
Why?
|
| Blood-Air Barrier | 1 | 2007 | 1 | 0.070 |
Why?
|
| Guanine Nucleotide Dissociation Inhibitors | 1 | 2007 | 2 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2007 | 127 | 0.070 |
Why?
|
| Mice, Transgenic | 3 | 2015 | 220 | 0.070 |
Why?
|
| Rats | 3 | 2019 | 628 | 0.070 |
Why?
|
| Mitochondria | 1 | 2007 | 61 | 0.070 |
Why?
|
| Coloring Agents | 1 | 2005 | 13 | 0.060 |
Why?
|
| Qa-SNARE Proteins | 1 | 2005 | 7 | 0.060 |
Why?
|
| Organometallic Compounds | 1 | 2005 | 17 | 0.060 |
Why?
|
| Escherichia coli | 1 | 2005 | 45 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2005 | 44 | 0.060 |
Why?
|
| Membrane Fusion | 1 | 2005 | 29 | 0.060 |
Why?
|
| Cholesterol | 1 | 2005 | 62 | 0.060 |
Why?
|
| CD11b Antigen | 1 | 2005 | 15 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2005 | 113 | 0.060 |
Why?
|
| Proteins | 1 | 2004 | 61 | 0.060 |
Why?
|
| CD18 Antigens | 1 | 2003 | 2 | 0.050 |
Why?
|
| Pulmonary Circulation | 1 | 2003 | 3 | 0.050 |
Why?
|
| Cell Line | 2 | 2015 | 276 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2003 | 94 | 0.050 |
Why?
|
| Gold Colloid | 1 | 2002 | 2 | 0.050 |
Why?
|
| Biological Transport, Active | 1 | 2002 | 7 | 0.050 |
Why?
|
| Nitrates | 1 | 2002 | 9 | 0.050 |
Why?
|
| Cross-Linking Reagents | 1 | 2002 | 13 | 0.050 |
Why?
|
| Tyrosine | 1 | 2002 | 19 | 0.050 |
Why?
|
| Perfusion | 1 | 2002 | 13 | 0.050 |
Why?
|
| Binding Sites | 1 | 2002 | 65 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2002 | 99 | 0.050 |
Why?
|
| Pneumonia | 1 | 2003 | 67 | 0.050 |
Why?
|
| Myocardium | 1 | 2002 | 94 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 2013 | 56 | 0.050 |
Why?
|
| Inflammation | 2 | 2015 | 277 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2013 | 305 | 0.040 |
Why?
|
| Cell Movement | 2 | 2016 | 80 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2021 | 176 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 280 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 117 | 0.040 |
Why?
|
| Pyrroles | 1 | 2019 | 17 | 0.040 |
Why?
|
| Hypoxia | 1 | 2019 | 28 | 0.040 |
Why?
|
| Biotin | 2 | 2011 | 7 | 0.040 |
Why?
|
| Glycosaminoglycans | 1 | 2017 | 20 | 0.030 |
Why?
|
| Hyaluronan Synthases | 1 | 2017 | 5 | 0.030 |
Why?
|
| Fibrosis | 1 | 2017 | 30 | 0.030 |
Why?
|
| Base Sequence | 2 | 2007 | 106 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2017 | 15 | 0.030 |
Why?
|
| Systole | 1 | 2017 | 15 | 0.030 |
Why?
|
| Hyaluronic Acid | 1 | 2017 | 55 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2017 | 15 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2017 | 23 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2016 | 5 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 13 | 0.030 |
Why?
|
| A549 Cells | 1 | 2016 | 10 | 0.030 |
Why?
|
| Collagen | 1 | 2017 | 81 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2016 | 14 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 646 | 0.030 |
Why?
|
| Lipids | 1 | 2017 | 48 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2007 | 82 | 0.030 |
Why?
|
| Pulmonary Edema | 2 | 2009 | 27 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2017 | 75 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 96 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 116 | 0.030 |
Why?
|
| Hyperesthesia | 1 | 2015 | 1 | 0.030 |
Why?
|
| Claudin-3 | 1 | 2015 | 1 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2015 | 4 | 0.030 |
Why?
|
| Claudin-1 | 1 | 2015 | 2 | 0.030 |
Why?
|
| Transgenes | 1 | 2015 | 11 | 0.030 |
Why?
|
| Tight Junctions | 1 | 2015 | 15 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 246 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2015 | 23 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2015 | 43 | 0.030 |
Why?
|
| RNA Interference | 1 | 2015 | 40 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 2015 | 18 | 0.030 |
Why?
|
| Cell Adhesion | 2 | 2005 | 30 | 0.030 |
Why?
|
| Homeostasis | 1 | 2015 | 69 | 0.030 |
Why?
|
| Seizures | 1 | 2015 | 70 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 117 | 0.030 |
Why?
|
| Ataxia | 1 | 2015 | 75 | 0.030 |
Why?
|
| Helminth Proteins | 2 | 2005 | 14 | 0.030 |
Why?
|
| Cytokines | 1 | 2015 | 231 | 0.030 |
Why?
|
| Glycoproteins | 2 | 2005 | 49 | 0.030 |
Why?
|
| Proteolysis | 1 | 2013 | 7 | 0.030 |
Why?
|
| Granzymes | 1 | 2013 | 7 | 0.030 |
Why?
|
| Cations | 1 | 2013 | 11 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2013 | 24 | 0.030 |
Why?
|
| Transfection | 1 | 2013 | 115 | 0.030 |
Why?
|
| Models, Animal | 1 | 2013 | 108 | 0.030 |
Why?
|
| Lung Injury | 1 | 2013 | 10 | 0.030 |
Why?
|
| src Homology Domains | 1 | 2011 | 2 | 0.020 |
Why?
|
| Clathrin | 1 | 2011 | 4 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 2011 | 7 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 301 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 148 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2009 | 5 | 0.020 |
Why?
|
| rho-Associated Kinases | 1 | 2009 | 3 | 0.020 |
Why?
|
| Wiskott-Aldrich Syndrome Protein | 1 | 2009 | 2 | 0.020 |
Why?
|
| Actin-Related Protein 2-3 Complex | 1 | 2009 | 2 | 0.020 |
Why?
|
| Pseudopodia | 1 | 2009 | 5 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 50 | 0.020 |
Why?
|
| Biological Transport | 1 | 2007 | 37 | 0.020 |
Why?
|
| rho-Specific Guanine Nucleotide Dissociation Inhibitors | 1 | 2007 | 2 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2007 | 10 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2007 | 14 | 0.020 |
Why?
|
| Brain | 1 | 2015 | 1604 | 0.020 |
Why?
|
| CD47 Antigen | 1 | 2005 | 1 | 0.020 |
Why?
|
| Class Ib Phosphatidylinositol 3-Kinase | 1 | 2005 | 1 | 0.020 |
Why?
|
| Bronchopulmonary Sequestration | 1 | 2005 | 2 | 0.020 |
Why?
|
| Integrin beta3 | 1 | 2005 | 3 | 0.020 |
Why?
|
| Cell-Free System | 1 | 2005 | 2 | 0.020 |
Why?
|
| Streptavidin | 1 | 2005 | 3 | 0.020 |
Why?
|
| SNARE Proteins | 1 | 2005 | 13 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2005 | 48 | 0.020 |
Why?
|
| Gram-Negative Bacteria | 1 | 2005 | 23 | 0.010 |
Why?
|
| Oxidants | 1 | 2005 | 27 | 0.010 |
Why?
|
| Edema | 1 | 2005 | 25 | 0.010 |
Why?
|
| Protein Binding | 1 | 2005 | 114 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2003 | 2 | 0.010 |
Why?
|
| Dynamins | 1 | 2003 | 4 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 2003 | 8 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 29 | 0.010 |
Why?
|
| Chemokine CXCL2 | 1 | 2003 | 2 | 0.010 |
Why?
|
| Respiratory Burst | 1 | 2003 | 10 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2003 | 27 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2003 | 14 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2003 | 63 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 7517 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 89 | 0.010 |
Why?
|
| Chemokines | 1 | 2003 | 21 | 0.010 |
Why?
|
| Leukocytes | 1 | 2003 | 34 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 8556 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2003 | 319 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 8658 | 0.010 |
Why?
|